Related Experiment Video
Updated: Feb 13, 2026
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
21.8K
Acute Hepatic Allograft Rejection in Pediatric Recipients: Effective Factors
S M Dehghani1, I Shahramian2, M Afshari3
1Professor of Pediatric Gastroenterology, Shiraz University of Medical Sciences, Shiraz, Iran.
International Journal of Organ Transplantation Medicine
|March 14, 2018
Summary
This study found no significant clinical risk factors for acute cellular rejection (ACR) in liver transplant recipients. Further research is needed to understand ACR development and improve graft survival.
Area of Science:
- Hepatology
- Transplant Immunology
- Clinical Medicine
Background:
- Acute cellular rejection (ACR) is a reversible complication impacting liver allograft survival.
- Understanding factors associated with ACR is crucial for optimizing post-transplant outcomes.
Purpose of the Study:
- To investigate the relationship between ACR and various clinical factors in liver transplant recipients.
- To identify potential predictors of acute cellular rejection.
Main Methods:
- A retrospective analysis of 47 liver transplant recipients.
- Data collection included patient demographics, donor type, and clinical parameters.
- Statistical analysis to assess the significance of risk factors for ACR.
Main Results:
- 81% of recipients experienced ACR within 24 months post-transplantation.
- No statistically significant association was found between ACR and factors such as blood group, sex, age, donor type, or disease severity scores (Child score/class).
Conclusions:
- This study did not identify any significant clinical risk factors associated with ACR in liver transplant recipients within the observed follow-up period.
- The findings highlight the need for further investigation into the complex mechanisms underlying ACR.
Related Concept Videos
01:16Hepatic Drug Excretion: Influencing Factors
609
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
609
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.7K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.7K
01:17Hypothesis: Accept or Fail to Reject?
29.6K
The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.6K
01:02Quantifying and Rejecting Outliers: The Grubbs Test
4.2K
Sometimes, a data set can have a recorded numerical observation that greatly deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier. To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This...
4.2K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
01:21Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K